These top 5 stories underscore how 2025 was a year of constant friction at the intersection of public health and political ...

Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in ...

Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...

Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH ...

Panelists discuss how schizophrenia typically evolves through distinct phases—from first-episode psychosis to chronic illness ...

From there, the discussion turns to bispecific antibodies for relapsed/refractory multiple myeloma (RRMM) and the unmet needs ...